live attenuated malaria vaccine designed protect hepatic cd8+ t cell immunity 
goal develop vaccine sustainably prevents plasmodium falciparum pf malaria > % recipients pf sporozoites pf spz administered mosquito bites immunogens shown induce protection humans protection thought mediated cd8+ t cells liver secrete interferon-gamma ifn-gamma report purified irradiated pf spz administered volunteers needle inoculation skin safe suboptimally immunogenic protective animal studies demonstrated intravenous immunization critical inducing high frequency pf spz-specific cd8+ ifn-gamma-producing t cells liver nonhuman primates mice conferring protection mice results suggest intravenous administration vaccine will lead prevention infection pf malaria 
